Press

Beckley Retreats Advances Research to Combat Veteran Suicide Through Psychedelic Retreats

Jul 14 • 4 min read

Beckley Retreats, a psilocybin retreats and holistic wellbeing company, today celebrated its ongoing work in veteran suicide prevention by renewing a strategic partnership with the Heroic Hearts Project and Imperial College London (ICL) to further ICL’s research on the benefits of psychedelic-assisted therapies in combatting the veteran suicide epidemic among American service members. According to…

Opinion paper calls for clarity on the definition of “psychedelic-assisted therapy” using psilocybin

Jul 14 • 4 min read

COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the publication of a paper in the American Journal of Psychiatry that examines the definition of “psychedelic-assisted psychotherapy” using psilocybin and offers a new way of thinking about and describing this potential new treatment in psychiatry. The article…

BetterLife Highlights American College of Physicians’ Updated Guidelines for Treating Depression and Announces Closing of Private Placement

Jul 14 • 3 min read

BetterLife Pharma Inc. (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to highlight the American College of Physician’s (“ACP”) guidelines for the treatment of Major Depressive Disorder (“MDD”) published recently in Annals of Internal Medicine as an article titled “Nonpharmacologic and Pharmacologic Treatments of…

Cybin Announces the Development of a Scalable Psychedelic Facilitation Training Program, EMBARKCT

Jul 12 • 4 min read

Cybin Inc. (NEO:CYBN / NYSE American:CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, today announced that it has commenced the development of a streamlined, scalable version of its EMBARK Training Program, known as EMBARKCT. The EMBARK psychedelic facilitator training program was launched in October 2021 and…

Lucy Scientific Discovery Inc. Unveils New Sleep Aid Product: Twilight by Lucy

Jul 12 • 3 min read

Lucy Scientific Discovery Inc. (NASDAQ: LSDI), an innovator in psychotropic drug development, proudly announces the launch of “Twilight” – a blend of Amanita and Reishi mushrooms that include a variety of other nootropics promoting improved cognitive function and enhanced sleep quality. This release comes on the heels of the recent launch of “Mindful” by Lucy….

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435